© Copyright 2025 American Medical Association. All rights reserved.
Laparoscopic pancreatic islet cell transplantation is a surgical procedure designed to treat individuals with type I diabetes who experience significant challenges in managing their blood sugar levels through insulin therapy alone. This innovative treatment involves the extraction of insulin-producing cells, known as the Islets of Langerhans, from a donor pancreas. These cells are then purified in a laboratory setting before being introduced into the recipient's liver via the portal vein. The portal vein serves as a critical pathway, allowing the transplanted islet cells to migrate and attach themselves within the liver, where they can potentially resume their natural function of insulin production, provided that the surrounding conditions are conducive to their survival and activity. The laparoscopic approach to this procedure is characterized by its minimally invasive nature, which typically results in reduced recovery times and lower complication rates compared to traditional open surgical methods. It is important to note that while this procedure offers a promising solution for blood sugar control, patients may not achieve complete independence from insulin following a single infusion of islet cells, and additional transplant infusions may be necessary to optimize outcomes.
© Copyright 2025 Coding Ahead. All rights reserved.
The laparoscopic pancreatic islet cell transplantation procedure is indicated for patients with type I diabetes who have difficulty achieving stable blood sugar control through conventional insulin therapy. This procedure is particularly considered for individuals who experience severe hypoglycemic episodes or have other complications related to diabetes that significantly impact their quality of life.
The laparoscopic pancreatic islet cell transplantation procedure involves several critical steps to ensure successful transplantation of the islet cells into the recipient's liver.
Post-procedure care for patients who have undergone laparoscopic pancreatic islet cell transplantation includes regular monitoring of blood sugar levels to evaluate the function of the transplanted islet cells. Patients may require ongoing insulin therapy, especially if the islet cells do not achieve full functionality. Follow-up appointments are essential to assess the health of the transplanted cells and to manage any potential complications. Patients are also advised on lifestyle modifications and may need to adhere to immunosuppressive therapy to prevent rejection of the transplanted cells. Overall, the recovery process is closely managed to ensure the best possible outcomes for the patient.
| Short Descr | LAPAROSCOPIC ISLET TRANSPLNT | Medium Descr | LAPS PNCRTC ISLET CELL TRNSPLJ | Long Descr | Laparoscopy, surgical, pancreatic islet cell transplantation through portal vein | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Discontinued Code | Type of Service (TOS) | 2 - Surgery | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. | CCS Clinical Classification | 99 - Other OR gastrointestinal therapeutic procedures |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2012-01-01 | Deleted | Code deleted. See 48999 |
| 2007-01-01 | Added | Code added. |
Get instant expert-level medical coding assistance.